Table 4.
Effect of Clopidogrel Added to Aspirin on Fatal Hemorrhage in Longer-Term Follow-Up Trials
| Trial | Combination # of Events |
Aspirin Alone # of Events |
OR (95% CI) |
|---|---|---|---|
| SPS31 | NR | NR | ⋯ |
| CHARISMA10 | 26 | 17 | 1.53 (0.83–2.82) |
| CURE11 | 11 | 15 | 0.74 (0.34–1.61) |
| ACTIVE A12 | 42 | 27 | 1.57 (0.96–2.55) |
| CASCADE13 | 0 | 0 | 1.02* (0.02–52) |
| CREDO14 | NR | NR | ⋯ |
| REAL LATE-ZEST LATE15 | NR | NR | ⋯ |
| CASPAR16 | 2 | 1 | 2.01 (0.18–22) |
| All longer-term trials | 81 | 60 | 1.35 (0.97–1.90) |
NR indicates not reported.
Estimated by adding 0.5 to each cell.